Prestige Biologics Co., Ltd. (KOSDAQ:334970)

Prestige Biologics Revenue

Prestige Biologics had revenue of 1.17B KRW in the quarter ending September 30, 2025, with 241.37% growth. This brings the company's revenue in the last twelve months to 13.36B, up 736.63% year-over-year. In the fiscal year ending June 30, 2025, Prestige Biologics had annual revenue of 12.53B with 477.83% growth.

• Revenue (ttm): 13.36B
• Revenue Growth: +736.63%
• P/S Ratio: 16.76
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 223.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	12.53B	10.36B	477.83%
Jun 30, 2024	2.17B	423.21M	24.24%
Jun 30, 2023	1.75B	1.73B	11,115.88%
Dec 31, 2022	15.57M	-3.21B	-99.52%
Dec 31, 2021	3.23B	-	-